Awaiting resultsPhase IIINCT04340141
A021806 — perioperative vs adjuvant mFOLFIRINOX in resectable PDAC
Pancreas
Phase III; enrollment closed — perioperative vs adjuvant mFOLFIRINOX results pending.
Registry checked: 2026-10-29
Clinical trials explorer
Filter by cancer type, molecular target, phase, and recruitment status.
Loading filters…
Awaiting resultsPhase IIINCT05933577
V940-001 — intismeran autogene + pembrolizumab (high-risk melanoma, phase III)
Melanoma
Phase III confirmation; enrollment closed. Separate confirmatory trial of the KEYNOTE-942 phase IIb signal.
Registry checked: 2026-10-29